June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
(Pre)diabetes, higher levels of glucose variability, and glycemia are continuously associated with corneal neurodegeneration – The Maastricht Study
Author Affiliations & Notes
  • Sara Mokhtar
    University Eye Clinic Maastricht, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
    Department of Internal Medicine, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
  • Frank van der Heide
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Karel Oyaert
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Carla van der Kallen
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
    CARIM School for Cardiovascular Diseases, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
  • Tos TJM Berendschot
    University Eye Clinic Maastricht, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
    MHeNS School of Mental Health and Neuroscience, Universiteit Maastricht, Maastricht, Limburg, Netherlands
  • Yuri Forman
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Fabio Scarpa
    Department of Information Engineering, Azienda Ospedale Universita Padova, Padova, Veneto, Italy
  • Alessia Colonna
    Department of Information Engineering, Azienda Ospedale Universita Padova, Padova, Veneto, Italy
  • Bastiaan Gelan
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Marleen Greevenbroek
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Casper Schalkwijk
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Rudy Nuijts
    University Eye Clinic Maastricht, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
  • Miranda Schram
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Carroll Webers
    University Eye Clinic Maastricht, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
  • Coen Stehouwer
    Department of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, Limburg, Netherlands
  • Footnotes
    Commercial Relationships   Sara Mokhtar None; Frank van der Heide None; Karel Oyaert None; Carla van der Kallen None; Tos TJM Berendschot None; Yuri Forman None; Fabio Scarpa None; Alessia Colonna None; Bastiaan Gelan None; Marleen Greevenbroek None; Casper Schalkwijk None; Rudy Nuijts None; Miranda Schram None; Carroll Webers None; Coen Stehouwer None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5160. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sara Mokhtar, Frank van der Heide, Karel Oyaert, Carla van der Kallen, Tos TJM Berendschot, Yuri Forman, Fabio Scarpa, Alessia Colonna, Bastiaan Gelan, Marleen Greevenbroek, Casper Schalkwijk, Rudy Nuijts, Miranda Schram, Carroll Webers, Coen Stehouwer; (Pre)diabetes, higher levels of glucose variability, and glycemia are continuously associated with corneal neurodegeneration – The Maastricht Study. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5160.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neurodegeneration is a hallmark complication of type 2 diabetes (T2D). In the cornea, early morphological changes of nerve fibers are demonstrable using corneal confocal microscopy. We aim to assess the association of glucose metabolism status (GMS), indices of glucose variability, and continuous measures of glycemia with corneal nerve measures.

Methods : Population-based cross-sectional data from The Maastricht Study of N=3,471 participants (mean age 59.4 years, 48.4% men, 14.7% with prediabetes, and 21% with T2D). We used linear regression analyses to study the associations, after adjustment for demographic, and cardiovascular risk factors, between GMS n=3,471 (prediabetes, and T2D vs normal GMS), indices of glucose variability (incremental glucose peak n=1,201, and continuous glucose monitoring n=509), and continuous measures of glycemia (fasting plasma glucose n=3,470, 2-hour post-load glucose n=3,328, HbA1c n=3,468, skin autofluorescence n=3,254, and duration of T2D n=574) with a composite Z-score of corneal nerve fiber measures, and with individual corneal nerve measures (corneal nerve branch density, fiber density, fiber length, and fractal dimension). We used P for trend analyses for GMS.

Results : After full adjustment, a more adverse GMS was associated with a lower composite Z-score of corneal nerve measures (beta [95%CI], prediabetes vs normal GMS -0.08 [-0.17; 0.03]; T2D vs normal GMS status -0.14 [-0.25; -0.04]; P for trend = 0.001). Analogously, higher levels of incremental glucose peak per SD, -0.04 [-0.12; 0.05], continuous glucose monitoring-assessed SD per SD, -0.09 [-0.24; 0.06], fasting plasma glucose per SD, -0.09 [-0.13; -0.05], 2-hour post-load glucose -0.07 [-0.11; -0.03], HbA1c -0.08 [-0.11; -0.04], skin autofluorescence -0.05 [-0.08; -0.01], and duration of T2D -0.09 [-0.17; -0.00] were all associated with a lower composite Z-score of corneal nerve measures. In general, directionally similar associations were observed for individual corneal nerve measures.

Conclusions : This is the first population-based study to show that a more adverse GMS and higher levels of glucose variability and measures of glycemia are linearly and independently associated with corneal neurodegeneration; these data suggest that glycemia-associated corneal neurodegeneration is a continuous process that already starts before the onset of T2D.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×